IL1B and Alzheimer disease: Previously, we showed [23] that exposure to AD-related factors, such as Aβ40/42 peptides, or indirect treatment with activated astrocyte-conditioned medium (treated with Aβ40/42/IL-1β/TNFα) has an inhibitory effect on the proliferation rate of NGC0211 cells.